\BOOKMARK [1][-]{section.1}{1. Introduction}{}% 1
\BOOKMARK [2][-]{subsection.1.1}{1.1. Outline}{section.1}% 2
\BOOKMARK [1][-]{section.2}{2. Analysis of case-count data}{}% 3
\BOOKMARK [2][-]{subsection.2.1}{2.1. Imperfect testing}{section.2}% 4
\BOOKMARK [2][-]{subsection.2.2}{2.2. Regrettable rates: complex biases resulting from self-selection}{section.2}% 5
\BOOKMARK [2][-]{subsection.2.3}{2.3. Estimation of effective reproduction number}{section.2}% 6
\BOOKMARK [2][-]{subsection.2.4}{2.4. Effect modifiers in COVID-19 clinical trials}{section.2}% 7
\BOOKMARK [1][-]{section.3}{3. Cross-population comparisons}{}% 8
\BOOKMARK [2][-]{subsection.3.1}{3.1. Prevalence comparisons}{section.3}% 9
\BOOKMARK [2][-]{subsection.3.2}{3.2. Case count comparisons}{section.3}% 10
\BOOKMARK [2][-]{subsection.3.3}{3.3. Rate comparisons}{section.3}% 11
\BOOKMARK [2][-]{subsection.3.4}{3.4. Estimation of Data Quality}{section.3}% 12
\BOOKMARK [1][-]{section.4}{4. Stratified sampling: improving precision in low-prevalence environments}{}% 13
\BOOKMARK [1][-]{section.5}{5. Discussion}{}% 14
\BOOKMARK [2][-]{section*.6}{Decision-making: data versus information}{section.5}% 15
\BOOKMARK [2][-]{section*.7}{High quality information on prevalence.}{section.5}% 16
\BOOKMARK [2][-]{section*.8}{Data quantity versus quality}{section.5}% 17
\BOOKMARK [2][-]{section*.9}{Model-based solutions.}{section.5}% 18
\BOOKMARK [1][-]{section*.10}{References}{}% 19
\BOOKMARK [1][-]{appendix.A}{Appendix A. Imperfect testing: derivation}{}% 20
\BOOKMARK [2][-]{subsection.A.1}{A.1. Estimate of observed data quality}{appendix.A}% 21
\BOOKMARK [2][-]{subsection.A.2}{A.2. Ratio estimator}{appendix.A}% 22
\BOOKMARK [2][-]{subsection.A.3}{A.3. Estimation of effective reproduction number}{appendix.A}% 23
\BOOKMARK [1][-]{appendix.B}{Appendix B. Derivation for the effective sample size}{}% 24
